|Company name||Laboratory Corp. of America Holdings|
|Live stock price||[stckqut]LH[/stckqut]|
|P/E compared to competitors||Good|
|Confident Investor Rating||Poor|
|Target stock price (TWCA growth scenario)||$82.57|
|Target stock price (averages with growth)||$107.3|
|Target stock price (averages with no growth)||$100.49|
|Target stock price (manual assumptions)||$88.75|
The following company description is from Google Finance: http://www.google.com/finance?q=lh
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in Laboratory Corp. of America Holdings.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.
For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.